Syndax Pharmaceuticals (SNDX) Free Cash Flow (2018 - 2026)
Syndax Pharmaceuticals (SNDX) free cash flow from Jun 30, 2018 to Mar 31, 2026. The TTM Syndax Pharmaceuticals (SNDX) free cash flow is -$278M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Syndax Pharmaceuticals (SNDX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -2.85% |
| 3 Years TTM | +28.57% |
| 5 Years TTM | +29.00% |
| All Time TTM | +29.81% |
Annual Free Cash Flow change of Syndax Pharmaceuticals (SNDX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$50M | -84.42% |
| 2025 | -$323M | +17.56% |
| 2024 | -$275M | +71.17% |
| 2023 | -$161M | +20.14% |
| 2022 | -$134M | -560.97% |
| 2021 | $29M | -140.70% |
| 2020 | -$71M | +40.80% |
| 2019 | -$51M | -26.35% |
| 2018 | -$69M | N/A |
Comparison Syndax Pharmaceuticals (SNDX) five years free cash flow CAGR with competitors
Syndax Pharmaceuticals (SNDX) five years free cash flow CAGR is 29.00%.